Cancer Clinical Trial
Official title:
A Brief Psychological Intervention Using Virtual Reality for the Promotion of Emotional Well-being in Hospitalized Cancer Patients
Verified date | March 2017 |
Source | University of Valencia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to analyze the effect of a brief psychological intervention supported by Information and Communication Technologies, on the subjective well-being of hospitalized cancer patients. Participants are randomly assigned to one of 2 conditions: Intervention condition (4 Virtual reality sessions) and Control condition (waiting list control group).
Status | Completed |
Enrollment | 76 |
Est. completion date | December 2011 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - adults with any cancer diagnosis - hospitalized for at least 1 week - Karnofsky functional state =50 - life expectancy =2 months Exclusion Criteria: - serious psychopathology - cognitive impairment |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Valencia | Hospital Clínica Benidorm, Universidad Politécnica de Valencia, Universitat Jaume I |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | The Brief Illness Perception Questionnaire (BIPQ) (Broadbent et al., 2006) | This instrument has 9 items aimed to evaluate the cognitive and emotional representation of the illness (consequences, timeline, personal control, treatment control, identity, concern, emotional response, illness coherence and causes). | baseline | |
Other | Personal meaning of the illness (ad-hoc). | Patient has 6 alternatives of illness meaning (Loss, threat, challenge, blame-others, blame-self and opportunity). In addition to these alternatives, participant can add any other personal meaning. | baseline | |
Other | Visual Analog Scale: Optimism | 11-point scale (not at all - completely) | baseline | |
Other | Visual Analog Scale: Life satisfaction | 7-point scale (no satisfaction - completely satisfied) | baseline | |
Primary | The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983; adapted version of Tejero, Guimerá, Farré & Peri, 1986) | change from baseline at 1 week | ||
Primary | Fordyce Happiness Scale (Fordyce, 1988). | change from baseline at 1 week | ||
Secondary | Visual Analog Scale: Mood. | Subjective mood change after each intervention session. | 4 days along 1 week | |
Secondary | Visual Analog Scale: Emotional State. Change from pre to post session. | Assessment of general mood, joy, sadness, anxiety, relax and vigor (7-point Likert scale) | 4 days along 1 week | |
Secondary | Visual Analog Scale: Physical Discomfort. Change from pre to post session. | Presence of pain, fatigue and physical discomfort (11-point Likert scale) | 4 days along 1 week | |
Secondary | Visual Analog Scale: Satisfaction with the Session Scale. | Level of pleasantness and perceived usefulness of each session (11-point Likert scale) | 4 days along 1 week | |
Secondary | Satisfaction with Intervention Scale (adapted version of Borkovec and Nau's, 1972) | Assesses satisfaction, recommendation, utility and discomfort (11-point Likert scale) | 1 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|